Apellis Pharmaceuticals Share Price (NASDAQ: APLS)
$28.22
▲
0.29
(1.04%)
Last updated on
Check the interactive Apellis Pharmaceuticals Stock chart to analyse performance
Apellis Pharmaceuticals stock performance
as on August 28, 2025 at 1:29 am IST
- Today's Low:$27.81Today's High:$28.49
1.47%
Downside
Day's Volatility :2.4%
Upside
0.95%
- 52 Weeks Low:$16.1052 Weeks High:$41.94
42.95%
Downside
52 Weeks Volatility :61.61%
Upside
32.71%
Apellis Pharmaceuticals Stock Returns
Apellis Pharmaceuticals Inc Key Stats
Check Apellis Pharmaceuticals key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.
Stock Returns calculator for Apellis Pharmaceuticals Stock including INR - Dollar returns
The Apellis Pharmaceuticals stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Apellis Pharmaceuticals investment value today
Current value as on today
₹75,948
Returns
Returns from Apellis Pharmaceuticals Stock
Dollar Returns*
₹4,685 (+4.68%)
Indian investors sentiment towards Apellis Pharmaceuticals Stock
Global Institutional Holdings in Apellis Pharmaceuticals Inc
Name
Holdings %
venBio Select Advisor LLC
9.68%
EcoR1 Capital, LLC
9.42%
Vanguard Group Inc
8.04%
Morgan Stanley - Brokerage Accounts
7.62%
Wellington Management Company LLP
7.11%
Deep Track Capital, LP
5.54%
Analyst Recommendation on Apellis Pharmaceuticals Stock
Buy
82%Buy
17%Hold
0%Sell
Based on 23 Wall street analysts offering stock ratings for Apellis Pharmaceuticals(by analysts ranked 0 to 5 stars)
- Current
- 1M Ago
- 3M Ago
Apellis Pharmaceuticals Share Price Target
What analysts predicted
Upside of 36.63%
Target:
$38.56
Current:
$28.22
Apellis Pharmaceuticals share price target is $38.56, a slight Upside of 36.63% compared to current price of $28.22 as per analysts' prediction.
Apellis Pharmaceuticals Stock Insights
Price Movement
In the last 1 month, APLS stock has moved up by 42.7%Increasing Revenue
Revenue is up for the last 2 quarters, 166.79M → 178.49M (in $), with an average increase of 6.6% per quarterIncreasing Net Profit
Netprofit is up for the last 2 quarters, -92.22M → -42.15M (in $), with an average increase of 118.8% per quarterAPLS vs ALNY (1 yr)
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 61.0% return, outperforming this stock by 90.4%APLS vs ALNY (3 yr)
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 113.9% return, outperforming this stock by 163.8%Price to Sales
ForAPLS every $1 of sales, investors are willing to pay $4.7, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $23.9 for every $1 of sales.
Apellis Pharmaceuticals Technicals Summary
Sell
Neutral
Buy
Apellis Pharmaceuticals is currently in a favorable trading position ( BUY ) according to technical analysis indicators.
Apellis Pharmaceuticals Inc Vs Peers
| Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
|---|---|---|---|---|---|
| 49.07% | 7.5% | -26.79% | -51.89% | -9.34% |
 | 5.25% | -16.41% | -51.02% | -0.89% | -5.24% |
 | 0.7% | 10.59% | 55.36% | 84.02% | 27.45% |
 | -17.38% | -18.44% | -20.97% | 37.43% | 38.65% |
 | 36.48% | 90.27% | 60.71% | 115.82% | 240.11% |
| Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
|---|---|---|---|---|---|---|---|---|
| NA | NA | NA | -0.4 | -1.08 | -0.14 | NA | 1.24 |
| 14.86 | 14.86 | 1.21 | 39.42 | 0.15 | 0.07 | 0.0 | 287.55 |
| NA | NA | NA | 2.29 | -0.05 | -0.01 | NA | 34.32 |
| 27.64 | 27.64 | 0.58 | 18.06 | 0.23 | 0.13 | NA | 67.02 |
| NA | NA | -0.49 | 3.92 | -2.58 | -0.03 | NA | 1.91 |
| Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
|---|---|---|---|---|---|
| Buy | $3.5B | -9.34% | NA | -30.24% |
| Buy | $62.5B | -5.24% | 14.86 | 31.37% |
| NA | $38.3B | 27.45% | NA | -3.89% |
| Buy | $99.7B | 38.65% | 27.64 | 31.86% |
| Buy | $58.2B | 240.11% | NA | -12.96% |
Apellis Pharmaceuticals Dividend announcements
Apellis Pharmaceuticals Earnings
Apellis Pharmaceuticals’s price-to-earnings ratio stands at None
About Apellis Pharmaceuticals Inc
Key Management of Apellis Pharmaceuticals Inc
Important FAQs about investing in APLS Stock from India :
What is Apellis Pharmaceuticals share price today?
Apellis Pharmaceuticals share price today is $28.22 as on at the close of the market. Apellis Pharmaceuticals share today touched a day high of $28.49 and a low of $27.81.
What is the 52 week high and 52 week low for Apellis Pharmaceuticals share?
Apellis Pharmaceuticals share touched a 52 week high of $41.94 and a 52 week low of $16.10. Apellis Pharmaceuticals stock price today i.e. is closed at $28.22, lower by 32.71% versus the 52 week high.
How to invest in Apellis Pharmaceuticals Stock (APLS) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Apellis Pharmaceuticals on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Apellis Pharmaceuticals Shares that will get you 0.0532 shares as per Apellis Pharmaceuticals share price of $28.22 per share as on August 28, 2025 at 1:29 am IST.
What is the minimum amount required to buy Apellis Pharmaceuticals Stock (APLS) from India?
Indian investors can start investing in Apellis Pharmaceuticals (APLS) shares with as little as ₹87.86 or $1 (as of August 28, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹878.60 in Apellis Pharmaceuticals stock (as per the Rupee-Dollar exchange rate as on August 28, 2025).
Based on Apellis Pharmaceuticals share’s latest price of $28.22 as on August 28, 2025 at 1:29 am IST, you will get 0.3544 shares of Apellis Pharmaceuticals. Learn more about
fractional shares .
What are the returns that Apellis Pharmaceuticals has given to Indian investors in the last 5 years?
Apellis Pharmaceuticals stock has given -9.34% share price returns and 18.89% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?
Discover More
Cullen/frost Bankers, Inc.$132.00
+0.06%
Plains Gp Holdings, L.p.$19.00
+1.55%
International Select Dividend Ishares$36.55
-0.35%
Pinnacle Financial Partners Inc$96.60
-0.62%
Shift4 Payments$90.37
+1.01%
Construction Partners Inc-a$121.30
-0.8%
Stoneco Ltd.$15.93
+1.66%
Element Solutions Inc$25.75
+0.31%
Intapp, Inc.$47.41
+5.26%